BackgroundSystematic assessment of right ventricular (RV) endocardial fibroelastosis (EFE) in the fetus with critical pulmonary stenosis and pulmonary atresia with intact ventricular septum (CPS/PA-IVS) has not been reported. The implications of RV EFE for circulatory outcomes with or without fetal cardiac intervention (FCI) have also not been demonstrated.MethodsThe fetal echocardiographic data from July 2018 to January 2021 in a single-center institution were collected. Three reviewers independently graded EFE according to the presence and extent of endocardial echogenicity. The associations among EFE severity, anatomic variables, and postnatal outcomes were analyzed.Results81 cases with RV EFE were identified. By consensus, EFE severity was assessed as grade 1 (“mild”; n=66, 81.48%), grade 2 (“moderate”; n=11, 13.58%), and grade 3 (“severe”; n=4, 4.94%). RV sphericity values were greater in grade 2 and 3 EFE groups compared to the grade 1 EFE group, implying more severe noncompliance and worse diastolic function. 10/81(12.35%) fetuses underwent FCI. At the latest available follow-up, 59/81 (72.84%) patients had achieved biventricular circulation. Furthermore, 9/59 (15.25%)—four with grade 1 EFE, three with grade 2, and two with grade 3—had undergone FCI, whereas the other 50/59 (84.75%)—who all had grade 1 EFE—had not.ConclusionsFor the first time in CPS/PA-IVS, RV EFE was graded and the potential of FCI to improve the prognosis of non-mild RV EFE patients was revealed. Non-mild RV EFE was suggested to be a putative indicator of FCI.Graphic Abstract
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.